• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的长期和短期预后:一项为期3年的随访研究。

Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study.

作者信息

Weinshenker B G, Issa M, Baskerville J

机构信息

Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.

出版信息

Arch Neurol. 1996 Apr;53(4):353-8. doi: 10.1001/archneur.1996.00550040093018.

DOI:10.1001/archneur.1996.00550040093018
PMID:8929158
Abstract

BACKGROUND

The anticipated rate of short-term worsening of disability scores is the basis of power estimations in clinical trials of progressive multiple sclerosis (MS). While the clinician is most concerned in modifying the long-term outcome (eg, time to reach the Expanded Disability Status Scale [EDSS]6), the end points studied in clinical trials are those describing short-term outcome (eg, worsening of EDSS scores over 1 to 3 years). However, short-term outcome of MS may not be correlated with long-term outcome.

OBJECTIVES

To validate previously published models predicting time to EDSS 6. To establish predictors of short-term outcome of MS.

SETTING

The Ottawa, Ontario, Regional Multiple Sclerosis Clinic.

PATIENTS

Two hundred fifty-nine patients were followed up prospectively by a single neurologist.

MAIN OUTCOME MEASURES

Actuarial analysis of time to reach EDSS 6 and change in EDSS scores over a follow-up period of 1 to 3 years.

RESULTS

The long-term outcome in the Ottawa population was more favorable than published data from London, Ontario. Predictions of time to EDSS 6 were not strongly correlated with the degree of short-term worsening over the follow-up period. Parameters associated with a higher probability of short-term worsening were proximity of the baseline EDSS score to 4.5 and duration of MS less than 20 years.

CONCLUSION

Baseline EDSS and duration of MS must be considered in the design of clinical trials of progressive MS.

摘要

背景

在进行性多发性硬化症(MS)的临床试验中,残疾评分短期恶化的预期速率是功效估计的基础。虽然临床医生最关心的是改变长期结局(例如,达到扩展残疾状态量表[EDSS]6分的时间),但临床试验中研究的终点是描述短期结局的指标(例如,1至3年内EDSS评分的恶化情况)。然而,MS的短期结局可能与长期结局不相关。

目的

验证先前发表的预测达到EDSS 6分时间的模型。确定MS短期结局的预测因素。

地点

安大略省渥太华地区多发性硬化症诊所。

患者

由一名神经科医生对259例患者进行前瞻性随访。

主要观察指标

对达到EDSS 6分的时间进行精算分析,并在1至3年的随访期内分析EDSS评分的变化。

结果

渥太华人群的长期结局比安大略省伦敦市公布的数据更有利。达到EDSS 6分时间的预测与随访期内短期恶化程度没有很强的相关性。与短期恶化可能性较高相关的参数是基线EDSS评分接近4.5以及MS病程少于20年。

结论

在进行性MS的临床试验设计中,必须考虑基线EDSS和MS病程。

相似文献

1
Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study.多发性硬化症的长期和短期预后:一项为期3年的随访研究。
Arch Neurol. 1996 Apr;53(4):353-8. doi: 10.1001/archneur.1996.00550040093018.
2
Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.儿童发病多发性硬化症患者延迟治疗对残疾的长期影响:一项前瞻性丹麦队列研究。
Mult Scler Relat Disord. 2020 May;40:101956. doi: 10.1016/j.msard.2020.101956. Epub 2020 Jan 17.
3
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.扩展残疾状态量表(EDSS)和多发性硬化功能综合评分(MSFC)在原发性进行性多发性硬化中的反应性和预测价值。
Neurology. 2008 Mar 25;70(13 Pt 2):1084-91. doi: 10.1212/01.wnl.0000288179.86056.e1. Epub 2008 Jan 9.
4
[Influence of acute aggravations on the development of long-term handicap in relapsing remitting multiple sclerosis: a clinical study in 99 patients].[急性加重对复发缓解型多发性硬化症长期残疾发展的影响:99例患者的临床研究]
Rev Neurol (Paris). 2007 Jan;163(1):72-81. doi: 10.1016/s0035-3787(07)90357-4.
5
Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.多发性硬化症的疾病阶段:一项比较疾病阶段和扩展残疾状态量表以评估疾病进展的纵向研究。
Mult Scler. 1999 Oct;5(5):349-54. doi: 10.1177/135245859900500508.
6
Mitoxantrone: a review of its use in multiple sclerosis.米托蒽醌:其在多发性硬化症中的应用综述
CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010.
7
Longitudinal follow-up of "benign" multiple sclerosis at 20 years.“良性”多发性硬化症20年的纵向随访
Neurology. 2007 Feb 13;68(7):496-500. doi: 10.1212/01.wnl.0000253185.03943.66.
8
One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.多发性硬化症患者残疾情况的一年变化:神经学检查与患者自我报告的比较
J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439-42. doi: 10.1136/jnnp.74.4.439.
9
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.在长期治疗环境中,那他珠单抗治疗显示出确认残疾恶化到 EDSS 里程碑的累积概率较低。
Mult Scler Relat Disord. 2018 Aug;24:11-19. doi: 10.1016/j.msard.2018.04.020. Epub 2018 May 2.
10
Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.随访中多发性硬化功能综合指标的应用:与疾病表型、残疾及治疗策略的关系
J Neurol Sci. 2005 May 15;232(1-2):65-9. doi: 10.1016/j.jns.2005.01.008.

引用本文的文献

1
Intrinsic ecto-5'-Nucleotidase/AR Coupling may Confer Neuroprotection to the Cerebellum in Experimental Autoimmune Encephalomyelitis.内在的ecto-5'-核苷酸酶/AR 偶联可能为实验性自身免疫性脑脊髓炎中的小脑提供神经保护作用。
Mol Neurobiol. 2024 Nov;61(11):9284-9301. doi: 10.1007/s12035-024-04174-9. Epub 2024 Apr 15.
2
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.低对比度视力测试与中枢炎症相关,并可预测新诊断的多发性硬化症患者的残疾进展。
Front Neurol. 2024 Feb 23;15:1326506. doi: 10.3389/fneur.2024.1326506. eCollection 2024.
3
Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis.
用于预测多发性硬化症患者临床疾病进展、恶化和活动的预后模型。
Cochrane Database Syst Rev. 2023 Sep 8;9(9):CD013606. doi: 10.1002/14651858.CD013606.pub2.
4
Personality as a Predictor of Disability in Multiple Sclerosis.人格特质对多发性硬化症致残的预测作用。
Arch Clin Neuropsychol. 2023 Jul 25;38(5):657-666. doi: 10.1093/arclin/acad010.
5
Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis.慢性实验性自身免疫性脑脊髓炎是研究多发性硬化症中神经轴突退变的极佳模型。
Front Mol Neurosci. 2022 Oct 19;15:1024058. doi: 10.3389/fnmol.2022.1024058. eCollection 2022.
6
Endogenous Neural Stem Cell Mediated Oligodendrogenesis in the Adult Mammalian Brain.内源性神经干细胞在成年哺乳动物大脑中的少突胶质细胞分化。
Cells. 2022 Jul 2;11(13):2101. doi: 10.3390/cells11132101.
7
Cerebellar Contributions to Motor Impairments in People with Multiple Sclerosis.小脑对多发性硬化症患者运动障碍的影响。
Cerebellum. 2022 Dec;21(6):1052-1060. doi: 10.1007/s12311-021-01336-6. Epub 2021 Oct 17.
8
The Protective Effect of Kolaviron on Molecular, Cellular, and Behavioral Characterization of Cerebellum in the Rat Model of Demyelinating Diseases.可乐维隆对脱髓鞘疾病大鼠模型小脑分子、细胞及行为特征的保护作用
Basic Clin Neurosci. 2020 Sep-Oct;11(5):609-618. doi: 10.32598/bcn.9.10.300. Epub 2020 Sep 1.
9
Preliminary Clinical Trial of Balance Compensation System for Improvement of Balance in Patients With Spinocerebellar Ataxia.用于改善脊髓小脑共济失调患者平衡能力的平衡补偿系统的初步临床试验
Ann Rehabil Med. 2020 Aug;44(4):284-291. doi: 10.5535/arm.19165. Epub 2020 Aug 5.
10
Reference videos reduce variability of motor dysfunction assessments in multiple sclerosis.参考视频可降低多发性硬化症运动功能障碍评估的变异性。
Mult Scler J Exp Transl Clin. 2018 Aug 9;4(3):2055217318792399. doi: 10.1177/2055217318792399. eCollection 2018 Jul-Sep.